Your using an article written in February 2011 as your basis for current FDA trend? Check this link to FDA approvals for this year. I believe current year has far surpassed previous in approvals. The link will take you to FDA site where you can filter down to the information needed. Great reference tool for any biotech investor.
Spotlight on Drug Innovation”: An ongoing update of FDA’s Center for Drug Evaluation and Research's novel drug approvals of calendar year 2011 The availability of new drugs often means new treatment options for patients, and advances in health care for the American public. For this reason, "innovation" is a key word throughout the pharmaceutical industry and the healthcare community. FDA's Center for Drug Evaluation and Research (CDER) regulates over-the-counter and brand name and generic prescription drugs. In this function, CDER supports innovation and plays a key role in helping to advance new drug development